137 related articles for article (PubMed ID: 35871048)
1. Implementing universal upfront multi-gene panel testing in endometrial cancer: From cost to practical considerations.
Levine MD; Barrington DA; Hampel H; Goodfellow PJ; Cohn DE
Gynecol Oncol; 2022 Sep; 166(3):538-542. PubMed ID: 35871048
[TBL] [Abstract][Full Text] [Related]
2. Utility of germline multi-gene panel testing in patients with endometrial cancer.
Karpel HC; Chern JY; Smith J M; Smith A J; Pothuri B
Gynecol Oncol; 2022 Jun; 165(3):546-551. PubMed ID: 35483985
[TBL] [Abstract][Full Text] [Related]
3. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
[TBL] [Abstract][Full Text] [Related]
4. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
5. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
6. Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study.
Levine MD; Pearlman R; Hampel H; Cosgrove C; Cohn D; Chassen A; Suarez A; Barrington DA; McElroy JP; Waggoner S; Nakayama J; Billingsley C; Resnick K; Andrews S; Singh S; Jenison E; Clements A; Neff R; Goodfellow PJ;
JCO Precis Oncol; 2021 Nov; 5():1588-1602. PubMed ID: 34994648
[TBL] [Abstract][Full Text] [Related]
7. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
[TBL] [Abstract][Full Text] [Related]
8. Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
Adar T; Rodgers LH; Shannon KM; Yoshida M; Ma T; Mattia A; Lauwers GY; Iafrate AJ; Hartford NM; Oliva E; Chung DC
Cancer; 2018 Aug; 124(15):3145-3153. PubMed ID: 29750335
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
10. An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach.
Dondi G; Coluccelli S; De Leo A; Ferrari S; Gruppioni E; Bovicelli A; Godino L; Coadă CA; Morganti AG; Giordano A; Santini D; Ceccarelli C; Turchetti D; De Iaco P; Perrone AM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003368
[TBL] [Abstract][Full Text] [Related]
11. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.
Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF
Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm
Mannucci A; Furniss CS; Ukaegbu C; Horiguchi M; Fehlmann T; Uno H; Yurgelun MB; Syngal S
J Clin Oncol; 2020 Dec; 38(34):4086-4094. PubMed ID: 32997573
[TBL] [Abstract][Full Text] [Related]
13. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
14. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
15. The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis.
Ryan NAJ; Glaire MA; Blake D; Cabrera-Dandy M; Evans DG; Crosbie EJ
Genet Med; 2019 Oct; 21(10):2167-2180. PubMed ID: 31086306
[TBL] [Abstract][Full Text] [Related]
16. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
17. Comparison of universal screening in major lynch-associated tumors: a systematic review of literature.
Kunnackal John G; Das Villgran V; Caufield-Noll C; Giardiello FM
Fam Cancer; 2022 Jan; 21(1):57-67. PubMed ID: 33426601
[TBL] [Abstract][Full Text] [Related]
18. Universal tumor screening in a population with MSH6- and PMS2-associated Lynch syndrome.
Einarsson H; Runarsdottir JR; Tryggvason T; Snaebjornsson P; Smaradottir A; Stefansdottir V; Thoroddsen A; Arngrimsson R; Jonasson JG; Haraldsdottir S
Genet Med; 2022 May; 24(5):999-1007. PubMed ID: 35172941
[TBL] [Abstract][Full Text] [Related]
19. Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer.
Eiriksson L; Aronson M; Clarke B; Mojtahedi G; Massey C; Oza AM; Gallinger S; Pollett A; Mackay H; Bernardini MQ; Ferguson SE
Gynecol Oncol; 2015 Feb; 136(2):311-6. PubMed ID: 25529831
[TBL] [Abstract][Full Text] [Related]
20. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]